New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
MannKind Corporation (MNKD) vs Nuvation Bio Inc. (NUVB)
- MannKind Corporation MNKD 3.91 −0.76%
- Nuvation Bio Inc. NUVB 3.78 −0.79%
MannKind Corporation and Nuvation Bio Inc. are both Biotechnology companies. MannKind Corporation and Nuvation Bio Inc. are of similar size ($1.4B and $1.4B). Nuvation Bio Inc. grew revenue faster over the last twelve months: 654.2% against 31.7%. MannKind Corporation has the higher net margin (−18.1% vs −67.4%) and the lower return on invested capital (−2.58% vs 0.00%). Across the 16 metrics below, MannKind Corporation leads on 10 and Nuvation Bio Inc. on 6.
Valuation
Profitability
| Metric | MNKD | NUVB | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.76% | 85.79% | 70.18% |
| Operating margin | (2.88%) | (61.17%) | 0.00% |
| Net margin | (18.10%) | (67.38%) | 0.00% |
| Free cash flow margin | (18.97%) | (53.62%) | 0.00% |
| Return on equity | 182.90% | (49.09%) | (51.58%) |
| Return on assets | (12.29%) | (19.70%) | (45.91%) |
| Return on invested capital | (2.58%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack